<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02475850</url>
  </required_header>
  <id_info>
    <org_study_id>U01AG048270</org_study_id>
    <secondary_id>1U01AG048270-01</secondary_id>
    <nct_id>NCT02475850</nct_id>
  </id_info>
  <brief_title>Strategies to Reduce Injuries and Develop Confidence in Elders</brief_title>
  <acronym>STRIDE</acronym>
  <official_title>Randomized Trial of a Multifactorial Fall Injury Prevention Strategy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Healthcare Partners</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas Medical Branch, Galveston</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mt Sinai Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Reliant Medical Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Partners HealthCare</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Iowa Health Alliance</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Essentia Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wake Forest University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this pragmatic cluster-randomized trial is to determine the effectiveness of an&#xD;
      evidence-based, patient-centered multifactorial fall injury prevention strategy in community&#xD;
      dwelling older adults at risk of falls recruited from 86 primary care practices around the&#xD;
      U.S.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: To determine the effectiveness of an evidence-based, patient-centered&#xD;
      multifactorial fall injury prevention strategy implemented within primary care practices&#xD;
      using usual health care resources&#xD;
&#xD;
      Design: This study is a cluster randomized, parallel group superiority trial with practices&#xD;
      stratified by healthcare system and patients nested within practices. The unit of&#xD;
      randomization is the practice.&#xD;
&#xD;
      Study Duration: The total study duration is 5 years. Recruitment will take place over 20&#xD;
      months, with follow-up taking place for 24 months - 44 months depending on date of&#xD;
      enrollment.&#xD;
&#xD;
      Trial Sites: 86 primary care practices that are part of 10 trial sites located around the&#xD;
      U.S.: The Partners' Health Care System; Essentia; Hopkins Health Care System; HealthCare&#xD;
      Partners; Reliant Health Care System; Mount Sinai Health Care System; University of&#xD;
      Pittsburgh Health Care System; University of Texas Medical Branch Health Care System;&#xD;
      University of Iowa Health Care System; University of Michigan Health Care System.&#xD;
&#xD;
      Number of Subjects: The original target sample size was 6,000 participants enrolled in 86&#xD;
      practices to provide 90% power to detect a 20% reduction in the rate of the primary outcome&#xD;
      with intervention relative to control. The study was originally designed for a study duration&#xD;
      of 36 months with 18 months of recruitment and a minimum of 18 months of follow-up. The study&#xD;
      was extended to a 44 month study (20 months of recruitment and a minimum 24 month of&#xD;
      follow-up). For a 44 month trial, it was estimated that a sample size of 5,322 subjects would&#xD;
      provide 90% power to detect a 20% reduction in the rate of the primary outcome with the&#xD;
      intervention relative to control.&#xD;
&#xD;
      Main Inclusion Criteria Community-living persons, 70 years or older, who are at increased&#xD;
      risk for serious fall injuries.&#xD;
&#xD;
      Intervention: An evidence-based patient-centered intervention that will combine elements of a&#xD;
      multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at&#xD;
      Yale, practice guidelines offered by the Center for Disease Control's (CDC's) &quot;STEADI&quot;&#xD;
      toolbox (Stopping Elderly Accidents, Disability and Injury) and the joint American Geriatrics&#xD;
      Society/British Geriatrics Society guidelines, and Assessing Care of Vulnerable Elders&#xD;
      (ACOVE) practice change approach. The fall prevention strategies will be systematically&#xD;
      implemented into clinical practice using: delivery system design to improve quality&#xD;
      (Co-management); decision support (algorithms); information systems (software);&#xD;
      self-management support (patient/caregiver engagement and activation); and linkage to&#xD;
      community-based resources.&#xD;
&#xD;
      Primary Outcome: The primary outcome is adjudicated serious fall injuries, operationalized as&#xD;
      a fall resulting in: (1) (fracture other than thoracic/lumbar vertebral; joint dislocation;&#xD;
      or cut requiring closure) AND any medical attention; OR (2) (head injury; sprain or strain;&#xD;
      bruising or swelling; or other) requiring hospitalization.&#xD;
&#xD;
      Primary Analysis: The risk of any serious fall injury (i.e., time to first event) will be&#xD;
      analyzed using a survival model that incorporates competing risks (due to death) and&#xD;
      clustering. In this analysis, participants who are lost to follow-up without a prior serious&#xD;
      fall-related injury will be censored at their date last seen. In a sensitivity analysis, the&#xD;
      investigators will adjust for the pre-specified set of baseline covariates to examine their&#xD;
      influence on the intervention effect.&#xD;
&#xD;
      Secondary Outcomes: All self-reported falls, all self-reported fall-related injuries, and&#xD;
      measures of well-being.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Actual">January 2020</completion_date>
  <primary_completion_date type="Actual">December 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First Adjudicated Serious Fall-Related Injury</measure>
    <time_frame>Enrollment through last completed follow-up or death interview (max 44 months)</time_frame>
    <description>Number of first adjudicated serious fall-related injury serious fall-related injury events per 100 per years of follow-up.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First Self-reported Fall-related Injury</measure>
    <time_frame>Enrollment through last completed follow-up or death interview (max 44 months)</time_frame>
    <description>Number of first self-reported fall-related injuries per 100 per years of follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Self-reported Falls</measure>
    <time_frame>these data were not collected</time_frame>
    <description>** data for this outcome was not collected</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Function</measure>
    <time_frame>measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores</time_frame>
    <description>Late Life Function and Disability Instrument (LL-FDI) function score. The scores are on a 0-100 scale, higher score = better function. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability</measure>
    <time_frame>measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores</time_frame>
    <description>Late Life Function and Disability Instrument (LL-FDI) disability score. The scores are on a 0-100 scale, higher score = less disability. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.</time_frame>
    <description>Patient-reported Outcome Measure Information System (PROMIS) Anxiety subscale. Measured on a 8-40 Scale, higher score = more anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.</time_frame>
    <description>PROMIS depression subscale. Measured on a 8-40 Scale, higher score = more depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fear of Falling</measure>
    <time_frame>Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.</time_frame>
    <description>Falls Efficacy Scale. Measured on a 10-40 Scale, higher score = more fear of falling.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5451</enrollment>
  <condition>Accidental Falls</condition>
  <condition>Wounds and Injuries</condition>
  <arm_group>
    <arm_group_label>Fall prevention standard of care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's &quot;STEADI&quot; toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Usual fall prevention care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Evidence-based tailored fall prevention</intervention_name>
    <arm_group_label>Fall prevention standard of care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient is at least 70 years of age.&#xD;
&#xD;
          -  The patient must answer 'yes' to one or more of the following questions:&#xD;
&#xD;
          -  Have you fallen and hurt yourself in the past year?&#xD;
&#xD;
          -  Have you fallen 2 or more times in the past year?&#xD;
&#xD;
          -  Are you afraid that you might fall because of balance or walking problems?&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient is enrolled in hospice.&#xD;
&#xD;
          -  The patient resides in a nursing home.&#xD;
&#xD;
          -  The patient is not capable of providing informed consent (or assent), and a proxy is&#xD;
             not available.&#xD;
&#xD;
          -  The patient does not speak English or Spanish&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shalender Bhasin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Gill, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dave Reuben, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nancy Latham, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Brigham and Women's Hosptial</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Healthcare Partners</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Health Alliance</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Partners Healthcare</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reliant Medical Group</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Essentia Health</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mt Sinai Health System</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch at Galveston</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 1, 2015</study_first_submitted>
  <study_first_submitted_qc>June 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2015</study_first_posted>
  <results_first_submitted>January 13, 2021</results_first_submitted>
  <results_first_submitted_qc>March 2, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 3, 2021</results_first_posted>
  <last_update_submitted>March 2, 2021</last_update_submitted>
  <last_update_submitted_qc>March 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Nancy Latham</investigator_full_name>
    <investigator_title>Study Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 25, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/50/NCT02475850/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 31, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/50/NCT02475850/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intervention - Fall Prevention Standard of Care</title>
          <description>An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's &quot;STEADI&quot; toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach&#xD;
Evidence-based tailored fall prevention</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Usual fall prevention care&#xD;
Usual care</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2802"/>
                <participants group_id="P2" count="2649"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2209"/>
                <participants group_id="P2" count="2165"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="593"/>
                <participants group_id="P2" count="484"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="155"/>
                <participants group_id="P2" count="141"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="217"/>
                <participants group_id="P2" count="188"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="221"/>
                <participants group_id="P2" count="155"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>Usual fall prevention care&#xD;
Usual care</description>
        </group>
        <group group_id="B2">
          <title>Intervention</title>
          <description>An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's &quot;STEADI&quot; toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach&#xD;
Evidence-based tailored fall prevention</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2649"/>
            <count group_id="B2" value="2802"/>
            <count group_id="B3" value="5451"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79.5" spread="5.8"/>
                    <measurement group_id="B2" value="79.9" spread="5.7"/>
                    <measurement group_id="B3" value="79.7" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1629"/>
                    <measurement group_id="B2" value="1752"/>
                    <measurement group_id="B3" value="3381"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1020"/>
                    <measurement group_id="B2" value="1050"/>
                    <measurement group_id="B3" value="2070"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="211"/>
                    <measurement group_id="B2" value="196"/>
                    <measurement group_id="B3" value="407"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2428"/>
                    <measurement group_id="B2" value="2592"/>
                    <measurement group_id="B3" value="5020"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="164"/>
                    <measurement group_id="B2" value="128"/>
                    <measurement group_id="B3" value="292"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2394"/>
                    <measurement group_id="B2" value="2571"/>
                    <measurement group_id="B3" value="4965"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Positive on Fall Risk Screening Questions</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Fallen 2 or more times in past year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="896"/>
                    <measurement group_id="B2" value="1015"/>
                    <measurement group_id="B3" value="1911"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fallen and hurt yourself in past year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1031"/>
                    <measurement group_id="B2" value="1089"/>
                    <measurement group_id="B3" value="2120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fear of falling because of balance or walking problems</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2274"/>
                    <measurement group_id="B2" value="2405"/>
                    <measurement group_id="B3" value="4679"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Educational Level</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>High school graduate or less</title>
                  <measurement_list>
                    <measurement group_id="B1" value="643"/>
                    <measurement group_id="B2" value="602"/>
                    <measurement group_id="B3" value="1245"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Some college or equivalent</title>
                  <measurement_list>
                    <measurement group_id="B1" value="659"/>
                    <measurement group_id="B2" value="697"/>
                    <measurement group_id="B3" value="1356"/>
                  </measurement_list>
                </category>
                <category>
                  <title>College graduate or higher</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1343"/>
                    <measurement group_id="B2" value="1502"/>
                    <measurement group_id="B3" value="2845"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronic coexisting conditions - number per participant</title>
          <units>number chronic conditions per subject</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.1" spread="1.3"/>
                    <measurement group_id="B2" value="2.1" spread="1.3"/>
                    <measurement group_id="B3" value="2.1" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinically significant cognitive impairment</title>
          <description>Four or more errors on 6-item Callahan cognitive screener OR the interview was completed entirely by proxy</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="160"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Use of mobility aid or inability to ambulate</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="909"/>
                    <measurement group_id="B2" value="972"/>
                    <measurement group_id="B3" value="1881"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of positive responses to screening questions regarding fall injuries</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>1</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1571"/>
                    <measurement group_id="B2" value="1634"/>
                    <measurement group_id="B3" value="3205"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="605"/>
                    <measurement group_id="B2" value="629"/>
                    <measurement group_id="B3" value="1234"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="473"/>
                    <measurement group_id="B2" value="539"/>
                    <measurement group_id="B3" value="1012"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of fracture other than of the hip after 50 yr of age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="876"/>
                    <measurement group_id="B2" value="918"/>
                    <measurement group_id="B3" value="1794"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of hip fracture after 50 years of age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                    <measurement group_id="B2" value="132"/>
                    <measurement group_id="B3" value="251"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>First Adjudicated Serious Fall-Related Injury</title>
        <description>Number of first adjudicated serious fall-related injury serious fall-related injury events per 100 per years of follow-up.</description>
        <time_frame>Enrollment through last completed follow-up or death interview (max 44 months)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention - Fall Prevention Standard of Care</title>
            <description>An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's &quot;STEADI&quot; toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach&#xD;
Evidence-based tailored fall prevention</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Usual fall prevention care&#xD;
Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>First Adjudicated Serious Fall-Related Injury</title>
          <description>Number of first adjudicated serious fall-related injury serious fall-related injury events per 100 per years of follow-up.</description>
          <units>events per 100 person years of follow-up</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2802"/>
                <count group_id="O2" value="2649"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.87" lower_limit="4.31" upper_limit="5.43"/>
                    <measurement group_id="O2" value="5.34" lower_limit="4.55" upper_limit="6.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.245</p_value>
            <p_value_desc>p&lt;0.05 threshold (primary outcome)</p_value_desc>
            <method>Regression, Cox</method>
            <method_desc>multistate model accounting for death as a semi-competing risk</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.92</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.80</ci_lower_limit>
            <ci_upper_limit>1.06</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Self-reported Fall-related Injury</title>
        <description>Number of first self-reported fall-related injuries per 100 per years of follow-up</description>
        <time_frame>Enrollment through last completed follow-up or death interview (max 44 months)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention - Fall Prevention Standard of Care</title>
            <description>An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's &quot;STEADI&quot; toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach&#xD;
Evidence-based tailored fall prevention</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Usual fall prevention care&#xD;
Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>First Self-reported Fall-related Injury</title>
          <description>Number of first self-reported fall-related injuries per 100 per years of follow-up</description>
          <units>events per 100 person years of follow-up</units>
          <param>Number</param>
          <dispersion>99% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2802"/>
                <count group_id="O2" value="2649"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.64" lower_limit="24.19" upper_limit="27.08"/>
                    <measurement group_id="O2" value="28.62" lower_limit="26.53" upper_limit="30.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.004</p_value>
            <p_value_desc>p&lt; 0.01 threshold (secondary outcome)</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.90</param_value>
            <ci_percent>99</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.83</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Self-reported Falls</title>
        <description>** data for this outcome was not collected</description>
        <time_frame>these data were not collected</time_frame>
        <population>These data were not collected</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention - Fall Prevention Standard of Care</title>
            <description>An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's &quot;STEADI&quot; toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach&#xD;
Evidence-based tailored fall prevention</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Usual fall prevention care&#xD;
Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Self-reported Falls</title>
          <description>** data for this outcome was not collected</description>
          <population>These data were not collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Physical Function</title>
        <description>Late Life Function and Disability Instrument (LL-FDI) function score. The scores are on a 0-100 scale, higher score = better function. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment</description>
        <time_frame>measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores</time_frame>
        <population>subsample selected for well-being measures with completed baseline LL-FDI</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention - Fall Prevention Standard of Care</title>
            <description>An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's &quot;STEADI&quot; toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach&#xD;
Evidence-based tailored fall prevention</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Usual fall prevention care&#xD;
Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Physical Function</title>
          <description>Late Life Function and Disability Instrument (LL-FDI) function score. The scores are on a 0-100 scale, higher score = better function. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment</description>
          <population>subsample selected for well-being measures with completed baseline LL-FDI</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="380"/>
                <count group_id="O2" value="358"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.45" spread="0.48"/>
                    <measurement group_id="O2" value="57.73" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.309</p_value>
            <p_value_desc>p &lt; 0.01 threshold (secondary outcome)</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>random: patients nested within practices; fixed: baseline score, randomization constraint vars, predictors of missingness</method_desc>
            <param_type>Difference in least-squared means across</param_type>
            <param_value>0.72</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.71</dispersion_value>
            <ci_percent>99</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.10</ci_lower_limit>
            <ci_upper_limit>2.54</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Disability</title>
        <description>Late Life Function and Disability Instrument (LL-FDI) disability score. The scores are on a 0-100 scale, higher score = less disability. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment</description>
        <time_frame>measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores</time_frame>
        <population>subsample selected for well-being measures with completed baseline LL-FDI</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention - Fall Prevention Standard of Care</title>
            <description>An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's &quot;STEADI&quot; toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach&#xD;
Evidence-based tailored fall prevention</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Usual fall prevention care&#xD;
Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Disability</title>
          <description>Late Life Function and Disability Instrument (LL-FDI) disability score. The scores are on a 0-100 scale, higher score = less disability. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment</description>
          <population>subsample selected for well-being measures with completed baseline LL-FDI</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="380"/>
                <count group_id="O2" value="358"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.16" spread="0.63"/>
                    <measurement group_id="O2" value="54.57" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.528</p_value>
            <p_value_desc>p &lt; 0.01 threshold (secondary outcome)</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>random: patients nested within practices; fixed: baseline score, randomization constraint vars, predictors of missingness</method_desc>
            <param_type>Least squares means</param_type>
            <param_value>0.59</param_value>
            <ci_percent>99</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.80</ci_lower_limit>
            <ci_upper_limit>0.93</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Anxiety</title>
        <description>Patient-reported Outcome Measure Information System (PROMIS) Anxiety subscale. Measured on a 8-40 Scale, higher score = more anxiety.</description>
        <time_frame>Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.</time_frame>
        <population>subsample selected for well-being measures and with completed baseline PROMIS Anxiety</population>
        <group_list>
          <group group_id="O1">
            <title>Fall Prevention Standard of Care</title>
            <description>An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's &quot;STEADI&quot; toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach&#xD;
Evidence-based tailored fall prevention</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Usual fall prevention care&#xD;
Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Anxiety</title>
          <description>Patient-reported Outcome Measure Information System (PROMIS) Anxiety subscale. Measured on a 8-40 Scale, higher score = more anxiety.</description>
          <population>subsample selected for well-being measures and with completed baseline PROMIS Anxiety</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="371"/>
                <count group_id="O2" value="350"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.63" spread="0.29"/>
                    <measurement group_id="O2" value="12.53" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.037</p_value>
            <p_value_desc>p &lt; 0.01 threshold (secondary outcome)</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>random: patients nested within practices; fixed: baseline score, randomization constraint vars, predictors of missingness</method_desc>
            <param_type>Least squares means</param_type>
            <param_value>-0.90</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.43</dispersion_value>
            <ci_percent>99</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.00</ci_lower_limit>
            <ci_upper_limit>0.20</ci_upper_limit>
            <estimate_desc>Difference in least-squared means across all follow-up (repeated measures: 12 months/24 months)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Depression</title>
        <description>PROMIS depression subscale. Measured on a 8-40 Scale, higher score = more depression.</description>
        <time_frame>Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.</time_frame>
        <population>subsample selected for well-being measures and with completed baseline PROMIS dep</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention - Fall Prevention Standard of Care</title>
            <description>An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's &quot;STEADI&quot; toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach&#xD;
Evidence-based tailored fall prevention</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Usual fall prevention care&#xD;
Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Depression</title>
          <description>PROMIS depression subscale. Measured on a 8-40 Scale, higher score = more depression.</description>
          <population>subsample selected for well-being measures and with completed baseline PROMIS dep</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="372"/>
                <count group_id="O2" value="350"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.75" spread="0.31"/>
                    <measurement group_id="O2" value="12.94" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.009</p_value>
            <p_value_desc>p&lt;0.01 threshold (secondary outcome)</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>random: patients nested within practices; fixed: baseline score, randomization constraint vars, predictors of missingness</method_desc>
            <param_type>Least squares means</param_type>
            <param_value>-1.19</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.45</dispersion_value>
            <ci_percent>99</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.36</ci_lower_limit>
            <ci_upper_limit>-0.02</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fear of Falling</title>
        <description>Falls Efficacy Scale. Measured on a 10-40 Scale, higher score = more fear of falling.</description>
        <time_frame>Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.</time_frame>
        <population>subsample selected for well-being measures and with completed baseline FES</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention - Fall Prevention Standard of Care</title>
            <description>An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's &quot;STEADI&quot; toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach&#xD;
Evidence-based tailored fall prevention</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Usual fall prevention care&#xD;
Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Fear of Falling</title>
          <description>Falls Efficacy Scale. Measured on a 10-40 Scale, higher score = more fear of falling.</description>
          <population>subsample selected for well-being measures and with completed baseline FES</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="372"/>
                <count group_id="O2" value="351"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.03" spread="0.35"/>
                    <measurement group_id="O2" value="16.10" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.897</p_value>
            <p_value_desc>p &lt;0.01 threshold (secondary outcome)</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>random: patients nested within practices; fixed: baseline score, randomization constraint vars, predictors of missingness</method_desc>
            <param_type>Least squares means</param_type>
            <param_value>-0.07</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.51</dispersion_value>
            <ci_percent>99</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.38</ci_lower_limit>
            <ci_upper_limit>1.25</ci_upper_limit>
            <estimate_desc>Difference in least-squared means across all follow-up (repeated measures: 12 months, 24 months)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Enrollment through death, withdrawal, or end of study (max 44 months)</time_frame>
      <desc>Only SAEs (death and hospitalization) were recorded. AEs were not collected in this pragmatic trial.</desc>
      <group_list>
        <group group_id="E1">
          <title>Intervention - Fall Prevention Standard of Care</title>
          <description>An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's &quot;STEADI&quot; toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach&#xD;
Evidence-based tailored fall prevention</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Usual fall prevention care&#xD;
Usual care</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="235" subjects_at_risk="2802"/>
                <counts group_id="E2" subjects_affected="220" subjects_at_risk="2649"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1139" subjects_at_risk="2802"/>
                <counts group_id="E2" subjects_affected="1108" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="29" subjects_affected="24" subjects_at_risk="2802"/>
                <counts group_id="E2" events="34" subjects_affected="29" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="270" subjects_affected="199" subjects_at_risk="2802"/>
                <counts group_id="E2" events="259" subjects_affected="199" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2802"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="2802"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="2802"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2802"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="208" subjects_affected="161" subjects_at_risk="2802"/>
                <counts group_id="E2" events="176" subjects_affected="135" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="194" subjects_affected="159" subjects_at_risk="2802"/>
                <counts group_id="E2" events="168" subjects_affected="152" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="2802"/>
                <counts group_id="E2" events="19" subjects_affected="17" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2802"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="324" subjects_affected="252" subjects_at_risk="2802"/>
                <counts group_id="E2" events="298" subjects_affected="231" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="225" subjects_affected="187" subjects_at_risk="2802"/>
                <counts group_id="E2" events="242" subjects_affected="196" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="22" subjects_affected="21" subjects_at_risk="2802"/>
                <counts group_id="E2" events="35" subjects_affected="32" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="59" subjects_affected="54" subjects_at_risk="2802"/>
                <counts group_id="E2" events="70" subjects_affected="55" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="205" subjects_affected="173" subjects_at_risk="2802"/>
                <counts group_id="E2" events="182" subjects_affected="156" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="59" subjects_affected="51" subjects_at_risk="2802"/>
                <counts group_id="E2" events="58" subjects_affected="52" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="230" subjects_affected="178" subjects_at_risk="2802"/>
                <counts group_id="E2" events="192" subjects_affected="153" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2802"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="31" subjects_affected="26" subjects_at_risk="2802"/>
                <counts group_id="E2" events="30" subjects_affected="24" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="54" subjects_affected="51" subjects_at_risk="2802"/>
                <counts group_id="E2" events="67" subjects_affected="55" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="2802"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="196" subjects_affected="156" subjects_at_risk="2802"/>
                <counts group_id="E2" events="156" subjects_affected="119" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="2802"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="2802"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="116" subjects_affected="101" subjects_at_risk="2802"/>
                <counts group_id="E2" events="135" subjects_affected="119" subjects_at_risk="2649"/>
              </event>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" events="72" subjects_affected="63" subjects_at_risk="2802"/>
                <counts group_id="E2" events="91" subjects_affected="77" subjects_at_risk="2649"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Erich Greene PhD</name_or_title>
      <organization>Yale University</organization>
      <phone>203-737-3636</phone>
      <email>erich.greene@yale.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

